HCA Healthcare Inc (NYSE:HCA) – Stock analysts at Cantor Fitzgerald cut their FY2017 earnings per share (EPS) estimates for HCA Healthcare in a research report issued to clients and investors on Thursday. Cantor Fitzgerald analyst J. France now expects that the company will post earnings per share of $6.60 for the year, down from their previous forecast of $7.15. Cantor Fitzgerald currently has a “Buy” rating and a $95.00 target price on the stock. Cantor Fitzgerald also issued estimates for HCA Healthcare’s FY2018 earnings at $8.00 EPS.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing analysts’ consensus estimates of $1.80 by ($0.05). The business had revenue of $10.73 billion for the quarter, compared to analysts’ expectations of $10.76 billion. The firm’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the previous year, the company earned $1.66 EPS.

WARNING: “HCA Healthcare Inc to Post FY2017 Earnings of $6.60 Per Share, Cantor Fitzgerald Forecasts (HCA)” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of United States and international trademark & copyright law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/23/hca-healthcare-inc-to-post-fy2017-earnings-of-6-60-per-share-cantor-fitzgerald-forecasts-hca.html.

Several other equities research analysts have also commented on the stock. ValuEngine lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday, September 7th. Argus started coverage on shares of HCA Healthcare in a research report on Wednesday, June 28th. They set a “buy” rating and a $100.00 price target for the company. KeyCorp reaffirmed a “buy” rating and set a $95.00 price target on shares of HCA Healthcare in a research report on Thursday, September 7th. BidaskClub lowered shares of HCA Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Finally, Bank of America Corporation lowered shares of HCA Healthcare from a “buy” rating to a “neutral” rating and reduced their price target for the company from $102.00 to $92.00 in a research report on Wednesday, July 26th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and seventeen have issued a buy rating to the stock. HCA Healthcare currently has a consensus rating of “Buy” and an average target price of $91.25.

HCA Healthcare (NYSE HCA) opened at 81.05 on Monday. The company has a market cap of $29.28 billion, a price-to-earnings ratio of 10.86 and a beta of 0.62. HCA Healthcare has a 12 month low of $67.00 and a 12 month high of $91.03. The firm’s 50-day moving average is $77.65 and its 200-day moving average is $81.88.

In other HCA Healthcare news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction that occurred on Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the transaction, the insider now directly owns 12,476 shares in the company, valued at approximately $973,128. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold a total of 6,450 shares of company stock valued at $511,163 over the last 90 days. 2.90% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently bought and sold shares of the business. Janney Montgomery Scott LLC boosted its position in shares of HCA Healthcare by 0.4% during the 2nd quarter. Janney Montgomery Scott LLC now owns 3,174 shares of the company’s stock valued at $277,000 after acquiring an additional 14 shares during the last quarter. Advisor Partners LLC boosted its position in shares of HCA Healthcare by 0.3% during the 2nd quarter. Advisor Partners LLC now owns 4,732 shares of the company’s stock valued at $413,000 after acquiring an additional 14 shares during the last quarter. Wetherby Asset Management Inc. boosted its position in shares of HCA Healthcare by 0.6% during the 2nd quarter. Wetherby Asset Management Inc. now owns 4,232 shares of the company’s stock valued at $369,000 after acquiring an additional 25 shares during the last quarter. Argent Capital Management LLC boosted its position in shares of HCA Healthcare by 1.2% during the 2nd quarter. Argent Capital Management LLC now owns 4,370 shares of the company’s stock valued at $381,000 after acquiring an additional 50 shares during the last quarter. Finally, Wedbush Securities Inc. boosted its position in shares of HCA Healthcare by 1.5% during the 2nd quarter. Wedbush Securities Inc. now owns 6,028 shares of the company’s stock valued at $526,000 after acquiring an additional 88 shares during the last quarter. Institutional investors and hedge funds own 73.76% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare Inc and related companies with MarketBeat.com's FREE daily email newsletter.